Product
Genomics Analysis
1 clinical trial
2 indications
Indication
Type 2 DiabetesIndication
Diabetic KetoacidosisClinical trial
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk (DaNGER)Status: Recruiting, Estimated PCD: 2024-06-06